Summit Trail Advisors LLC Acquires 4,494 Shares of Aflac Incorporated (NYSE:AFL)

Summit Trail Advisors LLC lifted its position in Aflac Incorporated (NYSE:AFL - Free Report) by 57.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,367 shares of the financial services provider's stock after buying an additional 4,494 shares during the quarter. Summit Trail Advisors LLC's holdings in Aflac were worth $1,383,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Lazard Asset Management LLC increased its holdings in shares of Aflac by 19.4% in the first quarter. Lazard Asset Management LLC now owns 1,520 shares of the financial services provider's stock worth $130,000 after purchasing an additional 247 shares during the period. Price T Rowe Associates Inc. MD increased its stake in Aflac by 1.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 882,906 shares of the financial services provider's stock worth $75,808,000 after acquiring an additional 12,357 shares during the last quarter. Bayesian Capital Management LP bought a new position in Aflac in the 1st quarter worth about $270,000. Motley Fool Asset Management LLC boosted its position in shares of Aflac by 5.9% during the 1st quarter. Motley Fool Asset Management LLC now owns 17,048 shares of the financial services provider's stock valued at $1,464,000 after acquiring an additional 956 shares during the last quarter. Finally, Creekmur Asset Management LLC increased its position in shares of Aflac by 10,946.2% in the first quarter. Creekmur Asset Management LLC now owns 5,744 shares of the financial services provider's stock worth $493,000 after purchasing an additional 5,692 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on AFL. UBS Group raised their price objective on shares of Aflac from $84.00 to $109.00 and gave the company a "neutral" rating in a research report on Wednesday, August 14th. Evercore ISI increased their price target on shares of Aflac from $84.00 to $90.00 and gave the company an "underperform" rating in a research report on Thursday, September 26th. JPMorgan Chase & Co. upped their price objective on shares of Aflac from $85.00 to $90.00 and gave the company a "neutral" rating in a research note on Thursday, October 3rd. Morgan Stanley increased their target price on Aflac from $91.00 to $98.00 and gave the company an "equal weight" rating in a report on Monday, August 19th. Finally, Wells Fargo & Company raised their target price on shares of Aflac from $106.00 to $107.00 and gave the stock an "equal weight" rating in a report on Tuesday, November 5th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Aflac presently has an average rating of "Hold" and a consensus target price of $97.93.

Aflac Stock Up 0.7 %

Shares of NYSE:AFL traded up $0.81 during trading on Monday, hitting $113.20. The stock had a trading volume of 3,663,734 shares, compared to its average volume of 2,221,631. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50. The company has a market capitalization of $62.89 billion, a PE ratio of 17.05, a PEG ratio of 2.17 and a beta of 0.96. The firm's fifty day moving average is $110.80 and its 200 day moving average is $100.85.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.47. The company had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. Aflac's quarterly revenue was down 40.4% compared to the same quarter last year. During the same period last year, the business earned $1.84 EPS. Analysts anticipate that Aflac Incorporated will post 7.22 EPS for the current fiscal year.

Aflac Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.77%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac's dividend payout ratio (DPR) is 30.12%.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.